Specialty drugs, such as those for hepatitis and cancer, are creating breakthroughs in health. But their impact on employers’ overall medical spend has been profound. 70% of Pharmacy cost growth in the past five years has been concentrated in these expensive medicines, totaling over $150 billion in 2015.

In this four-question quiz, you’ll find out if your specialty drug strategy is putting you at risk for unsustainable spending.